GlassScriptPhysician profile
Roger P Kierce
NPI 1740216605
$348.13
in general payments reported to CMS, 2019-2025
13 companies · $32.24 in 2025
The $32.24 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.27 · 2020: $48.51 · 2021: $74.05 · 2022: $99.84 · 2023: $50.22 · 2025: $32.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $59.25 | 2020-2021 | |
| Ethicon US, LLC | $45.01 | 2021-2022 | |
| Dysis Medical, INC. | $35.15 | 2022 | |
| Mayne Pharma Commercial LLC | $34.10 | 2023-2025 | |
| Exeltis, USA INC. | $30.14 | 2019-2025 | Slynd |
| Agile Therapeutics, INC. | $28.12 | 2022 | |
| Avion Pharmaceuticals | $26.91 | 2019-2020 | |
| Astellas Pharma US INC | $19.90 | 2023 | Veozah |
| Allergan, INC. | $14.61 | 2019 | |
| Cook Medical LLC | $14.22 | 2021 | |
| Pfizer INC. | $13.90 | 2022 | |
| Coopersurgical, INC. | $13.50 | 2021 | |
| Minerva Surgical, INC | $13.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Kierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.